WSC
ZBH icon

Wellington Shields & Co’s Zimmer Biomet ZBH Stock Holding History

Wellington Shields & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,648
Closed -$257K – 224
2021
Q2 		$257K Hold
1,648
– – 0.08% 174
2021
Q1 		$256K Buy
+1,648
New +$255K 0.09% 164

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wellington Shields & Co's ZBH Position: Q3 2021 in Review

Wellington Shields & Co sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 1,648 shares — an estimated $257K sold.

Wellington Shields & Co first reported a position in ZBH in Q1 2021 and held it in 2 quarters. The position peaked at $257K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

  • Wellington Shields & Co reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
  • Wellington Shields & Co sold 1,648 Zimmer Biomet shares in Q3 2021, an estimated $257K.
  • Wellington Shields & Co first reported a position in Zimmer Biomet in Q1 2021 and held it in 2 quarters.
  • Wellington Shields & Co's Zimmer Biomet position peaked at $257K in Q2 2021.
  • 982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Wellington Shields & Co's 13F filing for Q3 2021, filed 10 Nov 2021.